Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update

Back to Jobs

Webcast and Conference Call to be Held at 4:30 p.m. EST on March 4, 2019 SAN DIEGO , Feb. 25, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results

Apply Now